Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in G

Baxter Healthcare Corporation has issued a Class II recall for Vancomycin Injection, USP, in 0.9% Sodium Chloride (1g per 200 mL, 5 mg/mL) supplied in GALAXY Single-Dose Containers, NDC 0338-3583-01. According to the recall notice, the action was initiated due to CGMP deviations. The source did not specify the exact nature of the deviation or additional distribution details.

Most relevant for: patients receiving intravenous vancomycin therapy from recalled Baxter Healthcare batches in GALAXY Single-Dose Containers

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.